vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and IBEX Ltd (IBEX). Click either name above to swap in a different company.

IBEX Ltd is the larger business by last-quarter revenue ($164.2M vs $93.1M, roughly 1.8× HIVE Digital Technologies Ltd.). IBEX Ltd runs the higher net margin — 7.4% vs -98.1%, a 105.5% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 16.7%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 13.8%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

The IBEX 35 is the benchmark stock market index of the Bolsa de Madrid, Spain's principal stock exchange. Initiated in 1992, the index is administered and calculated by Sociedad de Bolsas, a subsidiary of Bolsas y Mercados Españoles (BME), the company which runs Spain's securities markets. It is a market capitalization-weighted index comprising the 35 most liquid Spanish stocks traded in the Madrid Stock Exchange General Index and is reviewed twice annually. Trading on options and futures con...

HIVE vs IBEX — Head-to-Head

Bigger by revenue
IBEX
IBEX
1.8× larger
IBEX
$164.2M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+201.8% gap
HIVE
218.6%
16.7%
IBEX
Higher net margin
IBEX
IBEX
105.5% more per $
IBEX
7.4%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
13.8%
IBEX

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
HIVE
HIVE
IBEX
IBEX
Revenue
$93.1M
$164.2M
Net Profit
$-91.3M
$12.2M
Gross Margin
-27.1%
Operating Margin
9.3%
Net Margin
-98.1%
7.4%
Revenue YoY
218.6%
16.7%
Net Profit YoY
-234.0%
31.8%
EPS (diluted)
$-0.38
$0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
IBEX
IBEX
Q4 25
$93.1M
$164.2M
Q3 25
$87.3M
$151.2M
Q2 25
$45.6M
$147.1M
Q1 25
$140.7M
Q4 24
$29.2M
$140.7M
Q3 24
$22.6M
$129.7M
Q2 24
$32.2M
$124.5M
Q1 24
$126.8M
Net Profit
HIVE
HIVE
IBEX
IBEX
Q4 25
$-91.3M
$12.2M
Q3 25
$-15.8M
$12.0M
Q2 25
$35.0M
$9.6M
Q1 25
$10.5M
Q4 24
$68.2M
$9.3M
Q3 24
$80.0K
$7.5M
Q2 24
$-18.3M
$9.8M
Q1 24
$10.3M
Gross Margin
HIVE
HIVE
IBEX
IBEX
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q1 25
Q4 24
-43.7%
Q3 24
-66.1%
Q2 24
-7.4%
Q1 24
Operating Margin
HIVE
HIVE
IBEX
IBEX
Q4 25
9.3%
Q3 25
9.1%
Q2 25
8.3%
Q1 25
9.5%
Q4 24
8.5%
Q3 24
7.0%
Q2 24
10.3%
Q1 24
8.9%
Net Margin
HIVE
HIVE
IBEX
IBEX
Q4 25
-98.1%
7.4%
Q3 25
-18.1%
8.0%
Q2 25
76.8%
6.5%
Q1 25
7.4%
Q4 24
233.2%
6.6%
Q3 24
0.4%
5.8%
Q2 24
-56.7%
7.9%
Q1 24
8.1%
EPS (diluted)
HIVE
HIVE
IBEX
IBEX
Q4 25
$-0.38
$0.83
Q3 25
$-0.07
$0.82
Q2 25
$0.18
$0.63
Q1 25
$0.73
Q4 24
$0.52
$0.57
Q3 24
$0.00
$0.43
Q2 24
$-0.17
$0.55
Q1 24
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
IBEX
IBEX
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
$594.0K
Stockholders' EquityBook value
$559.3M
$154.5M
Total Assets
$624.0M
$295.8M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
IBEX
IBEX
Q4 25
$15.5M
Q3 25
$22.7M
Q2 25
$15.3M
Q1 25
$13.0M
Q4 24
$40.5M
$20.2M
Q3 24
$31.7M
$62.3M
Q2 24
$62.7M
Q1 24
$50.7M
Total Debt
HIVE
HIVE
IBEX
IBEX
Q4 25
$594.0K
Q3 25
$726.0K
Q2 25
$796.0K
Q1 25
$735.0K
Q4 24
$695.0K
Q3 24
$802.0K
Q2 24
$867.0K
Q1 24
$820.0K
Stockholders' Equity
HIVE
HIVE
IBEX
IBEX
Q4 25
$559.3M
$154.5M
Q3 25
$624.6M
$143.6M
Q2 25
$560.5M
$134.3M
Q1 25
$124.2M
Q4 24
$430.9M
$108.9M
Q3 24
$275.5M
$171.1M
Q2 24
$268.6M
$165.8M
Q1 24
$159.3M
Total Assets
HIVE
HIVE
IBEX
IBEX
Q4 25
$624.0M
$295.8M
Q3 25
$693.0M
$283.9M
Q2 25
$628.7M
$273.2M
Q1 25
$274.7M
Q4 24
$478.6M
$272.5M
Q3 24
$334.7M
$306.3M
Q2 24
$293.9M
Q1 24
$289.6M
Debt / Equity
HIVE
HIVE
IBEX
IBEX
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.01×
Q3 24
0.00×
Q2 24
0.01×
Q1 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
IBEX
IBEX
Operating Cash FlowLast quarter
$46.0M
$6.6M
Free Cash FlowOCF − Capex
$-5.1M
FCF MarginFCF / Revenue
-3.1%
Capex IntensityCapex / Revenue
7.1%
Cash ConversionOCF / Net Profit
0.54×
TTM Free Cash FlowTrailing 4 quarters
$29.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
IBEX
IBEX
Q4 25
$46.0M
$6.6M
Q3 25
$-10.6M
$15.7M
Q2 25
$10.2M
$27.9M
Q1 25
$8.8M
Q4 24
$-28.5M
$1.1M
Q3 24
$-2.2M
$7.8M
Q2 24
$-4.4M
$17.4M
Q1 24
$11.4M
Free Cash Flow
HIVE
HIVE
IBEX
IBEX
Q4 25
$-5.1M
Q3 25
$8.0M
Q2 25
$22.8M
Q1 25
$3.6M
Q4 24
$-55.5M
$-3.2M
Q3 24
$-34.7M
$4.1M
Q2 24
$15.2M
Q1 24
$9.7M
FCF Margin
HIVE
HIVE
IBEX
IBEX
Q4 25
-3.1%
Q3 25
5.3%
Q2 25
15.5%
Q1 25
2.5%
Q4 24
-189.9%
-2.3%
Q3 24
-153.4%
3.2%
Q2 24
12.2%
Q1 24
7.7%
Capex Intensity
HIVE
HIVE
IBEX
IBEX
Q4 25
7.1%
Q3 25
5.1%
Q2 25
3.5%
Q1 25
3.7%
Q4 24
92.5%
3.1%
Q3 24
143.9%
2.8%
Q2 24
1.8%
Q1 24
1.3%
Cash Conversion
HIVE
HIVE
IBEX
IBEX
Q4 25
0.54×
Q3 25
1.30×
Q2 25
0.29×
2.91×
Q1 25
0.84×
Q4 24
-0.42×
0.12×
Q3 24
-26.94×
1.03×
Q2 24
1.77×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

IBEX
IBEX

Transferred Over Time$147.1M90%
Transferred At Point In Time$17.1M10%

Related Comparisons